<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3448">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04545242</url>
  </required_header>
  <id_info>
    <org_study_id>ICI20-00062</org_study_id>
    <nct_id>NCT04545242</nct_id>
  </id_info>
  <brief_title>Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions</brief_title>
  <acronym>DEXA-REFINE</acronym>
  <official_title>Efficacy of Dexamethasone Treatment for Patients With Acute Hypoxemic Respiratory Failure (Including ARDS) Caused by Infections (Including COVID-19)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Negrin University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Li Ka Shing Knowledge Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Consorcio Centro de Investigación Biomédica en Red, M.P.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dr. Negrin University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: There are no proven therapies specific for pulmonary dysfunction in patients with
      acute hypoxemic respiratory failure (AHRF) caused by infections (including Covid-19). The
      full spectrum of AHRF ranges from mild respiratory tract illness to severe pneumonia, acute
      respiratory distress syndrome (ARDS), multiorgan failure, and death. The efficacy of
      corticosteroids in AHRF and ARDS caused by infections remains controversial.

      Methods: This is a multicenter, randomized, controlled, open-label clinical trial testing
      dexamethasone in mechanically ventilated adult patients with established AHRF (including
      ARDS) caused by confirmed pulmonary or systemic infections, admitted in a network of Spanish
      ICUs. Eligible patients will be randomly assigned to receive dexamethasone: either 6 mg/d x
      10 days or 20 mg/d x 5 days followed by 10 mg/d x 5 days. The primary outcome is 60-day
      mortality. The secondary outcome is the number of ventilator-free days at 28 days. All
      analyses will be done according to the intention-to-treat principle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute hypoxemic respiratory failure (AHRF), and its more severe form termed the acute
      respiratory distress syndrome (ARDS), is a catastrophic illness of multifactorial etiology
      characterized by a severe inflammatory process of the lung leading to hypoxemic respiratory
      failure requiring mechanical ventilation (MV). Pulmonary infections are the leading causes of
      AHRF and ARDS. Translational research has established a strong association between
      dysregulated systemic and pulmonary inflammation and progression or delayed resolution of
      AHRF.2 Glucocorticoid receptor-mediated downregulation of systemic and pulmonary inflammation
      is essential to accelerate disease resolution and restore tissue homeostasis, and can be
      enhanced with glucocorticoid treatment.

      The COVID-19 pandemic is a critical moment for the world, in which even industrially advanced
      countries have rapidly reached intensive care units (ICUs) saturation, and intensivists are
      forced to make difficult ethical decisions that are uncommon outside war zones. As with other
      bacterial or viral infections, severe pneumonia is the main condition leading to AHRF and
      ARDS requiring weeks of MV with high mortality (35-55%) in critically ill patients. There has
      been great interest in the role of corticosteroids to attenuate the pulmonary and systemic
      damage in ARDS patients because of their potent anti-inflammatory and antifibrotic
      properties.3 Corticosteroids have been off patent for greater than 20 years, they are cheap,
      and globally equitable. However, the efficacy of corticosteroids in AHRF (including ARDS)
      caused by infections remains controversial.

      Only two large randomized clinical trials (RCT) have shown that the administration of
      dexamethasone is able to reduce mortality in patients with AHRF. Villar et al in Spain
      observed that moderate doses of dexamethasone (10-20 mg/d x 10 days) caused a 15% absolute
      reduction of 60-day mortality in patients with established moderate-to-severe ARDS from
      multiple etiologies. Horby et al in the RECOVERY trial in Great Britain reported that
      dexamethasone at low doses (6 mg/d x 10 days) reduced 28-day mortality in patients with AHRF
      caused by COVID-19. These findings confirmed that corticosteroid therapy is associated with a
      sizable reduction in duration of MV and hospital mortality. These two RCTs will change
      clinical practice for the management of AHRF and ARDS. However, there is a reasonable doubt
      whether dexamethasone at moderate doses (10-20 mg/d) would cause a greater reduction in
      mortality than 6 mg/d. Our goal in this study is to respond this question.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 7, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multicenter, randomized, controlled, open-label trial involving mechanically ventilated adult patients with AHRF (including ARDS) caused by confirmed bacterial or viral infections.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>60-day mortality</measure>
    <time_frame>60 days</time_frame>
    <description>All-cause mortality at 60 days after randomization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free days</measure>
    <time_frame>28 days</time_frame>
    <description>Number of ventilator-free days (VFDs) at Day 28 (defined as days being alive and free from mechanical ventilation at day 28 after randomization. For patients ventilated 28 days or longer and for subjects who die, VFD is 0.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">980</enrollment>
  <condition>Acute Hypoxemic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Dexamethasone (low dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone: 6 mg/iv/day during 10 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone (moderate dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone: 20 mg/iv/ daily from day of randomization (day 1) during 5 days, followed by 10 mg/iv/ daily from Day 6 to Day 10 of randomization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Intravenous dexamethasone (low vs. moderate doses) during 10 days</description>
    <arm_group_label>Dexamethasone (low dose)</arm_group_label>
    <arm_group_label>Dexamethasone (moderate dose)</arm_group_label>
    <other_name>Decadron</other_name>
    <other_name>Dexasone</other_name>
    <other_name>Diodex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 years or older;

          -  intubated and mechanically ventilated;

          -  acute onset of AHRF (as defined by a PaO2/FiO2 ≤300 mmHg during at least 6 hours from
             diagnosis. For the measurement of PaO2 and calculation of PaO2/FiO2 ratio, the minimum
             accepted value for PEEP is 5 cmH2O and for FiO2 is 0.3. ARDS is defined by Berlin
             criteria,4 which includes: (i) having pneumonia or worsening respiratory symptoms,
             (ii) bilateral pulmonary infiltrates on chest imaging (x-ray or CT scan), (iii)
             absence of left atrial hypertension or no clinical signs of left heart failure, and
             (iv) hypoxemia, as defined by a PaO2/FiO2 ≤300 mmHg on positive end-expiratory
             pressure (PEEP) of ≥5 cmH2O, regardless of FiO2.

          -  Pulmonary or systemic infectious etiology of AHRF.

        Exclusion Criteria:

          -  Patients with a known contraindication to corticosteroids,

          -  Patient included in another therapeutic clinical trial

          -  Lack of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesús Villar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Dr. Negrin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jesús Villar, MD</last_name>
    <phone>+34606860027</phone>
    <email>jesus.villar54@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arthur Slutsky, MD</last_name>
    <phone>+14168244000</phone>
    <email>Arthur.Slutsky@unityhealth.to</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario Mutua Terrassa (ICU)</name>
      <address>
        <city>Terrassa</city>
        <state>Barcelona</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>María M Fernández, MD</last_name>
      <phone>+34654027970</phone>
      <email>marufaes@yahoo.es</email>
    </contact>
    <contact_backup>
      <last_name>Josep Trenado, MD</last_name>
      <phone>+34630158583</phone>
      <email>jtrenado@mutuaterrassa.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital General La Mancha Centro (ICU)</name>
      <address>
        <city>Alcazar de San Juan</city>
        <state>Ciudad Real</state>
        <zip>13600</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Carmen Martin-Delgado, MD</last_name>
      <phone>+34628024856</phone>
      <email>carmenmartind35@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Santiago (Anesthesia)</name>
      <address>
        <city>Santiago De Compostela</city>
        <state>La Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Julián Álvarez, MD</last_name>
      <phone>+34606360187</phone>
      <email>julian.alvarez.escudero@sergas.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General El Bierzo (ICU)</name>
      <address>
        <city>Ponferrada</city>
        <state>León</state>
        <zip>24404</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Eleuterio Merayo, MD</last_name>
      <phone>+34619906005</phone>
      <email>emerayom@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Chanel Martínez, MD</last_name>
      <phone>+34630042686</phone>
      <email>chanel.mrtnz@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario del Henares (ICU)</name>
      <address>
        <city>Coslada</city>
        <state>Madrid</state>
        <zip>28822</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Federico Gordo, MD</last_name>
      <phone>+34630373288</phone>
      <email>fgordo5@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe (ICU)</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>José A Lorente, MD</last_name>
      <phone>+34649196626</phone>
      <email>joseangel.lorente@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>Raquel Herrero, MD</last_name>
      <email>raquelher@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro (ICU)</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Miguel A Romera, MD</last_name>
      <phone>+34639420622</phone>
      <email>miguelangel.romera@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Nuestra Señora del Prado (ICU)</name>
      <address>
        <city>Talavera De La Reina</city>
        <state>Toledo</state>
        <zip>45600</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Francisco Alba, MD</last_name>
      <phone>+34687823357</phone>
      <email>pacoalbagarcia@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ruth Corpas, MD</last_name>
      <phone>+34925803600</phone>
      <email>ruth_corpas@yahoo.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces (Anesthesia)</name>
      <address>
        <city>Barakaldo</city>
        <state>Vizcaya</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Gonzalo Tamayo, MD</last_name>
      <phone>+34655740637</phone>
      <email>gonzalotamayo@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Alberto Martínez-Ruiz, MD</last_name>
      <phone>+34610494664</phone>
      <email>alberto.martinezruiz@osakidetza.eus</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces (ICU)</name>
      <address>
        <city>Barakaldo</city>
        <state>Vizcaya</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Tomás Muñoz, MD</last_name>
      <phone>+34619576429</phone>
      <email>tomas.munozmartinez@osakidetza.net</email>
    </contact>
    <contact_backup>
      <last_name>Pablo Serna-Grande, MD</last_name>
      <phone>+34620686825</phone>
      <email>pablo.serna.grande@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Albacete (ICU)</name>
      <address>
        <city>Albacete</city>
        <zip>02006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Isabel Murcia, MD</last_name>
      <phone>+34609212303</phone>
      <email>murciasaez.im@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ángela Prado-Mira, MD</last_name>
      <phone>+34616624188</phone>
      <email>angge.86@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona (AVI)</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Pedro Castro, MD</last_name>
      <phone>+34645378213</phone>
      <email>PCASTRO@clinic.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona (Cardiac ICU)</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Manuel Castallá</last_name>
      <phone>+34696605769</phone>
      <email>MCASTE@clinic.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic (Hepatic ICU)</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Javier Fernández, MD</last_name>
      <phone>+34652421887</phone>
      <email>JFDEZ@clinic.cat</email>
    </contact>
    <contact_backup>
      <last_name>María Hernández, MD</last_name>
      <phone>+34636123288</phone>
      <email>mhernandezt@clinic.cat</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic de Barcelona (Anesthesia)</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Carlos Ferrando, MD</last_name>
      <phone>+34659583815</phone>
      <email>cafeoranestesia@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ricard Mellado-Artigas, MD</last_name>
      <phone>+34646217716</phone>
      <email>rmartigas@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital General de Ciudad Real (ICU)</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Alfonso Ambrós, MD</last_name>
      <phone>+34696544641</phone>
      <email>alfonsoa@sescam.jccm.es</email>
    </contact>
    <contact_backup>
      <last_name>Carmen Martín, MD</last_name>
      <phone>+34639931571</phone>
      <email>mcarmartin@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Luz (ICU)</name>
      <address>
        <city>Cuenca</city>
        <zip>16002</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Elena González, MD</last_name>
      <phone>+34669900472</phone>
      <email>elena03gon@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Rosario Solano, MD</last_name>
      <phone>+34636257419</phone>
      <email>charosolve@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de A Coruña (ICU)</name>
      <address>
        <city>La Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Fernando Mosteiro, MD</last_name>
      <phone>+346002645008</phone>
      <email>fernando.mosteiro.pereira@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Lidia Pita-García, MD</last_name>
      <phone>+34615459500</phone>
      <email>lidia.pita.garcía@sergas.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario de León (ICU)</name>
      <address>
        <city>León</city>
        <zip>24001</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Demetrio Carriedo, MD</last_name>
      <phone>+34669342578</phone>
      <email>dcarriedo@saludcastillayleon.es</email>
    </contact>
    <contact_backup>
      <last_name>Francisco J Díaz, MD</last_name>
      <phone>+34679195052</phone>
      <email>fjdmowi@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Princesa (ICU)</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Fernando Suarez-Sipmann, MD</last_name>
      <phone>+34669792961</phone>
      <email>fsuarezsipmann@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal (Anesthesia)</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>David Pestaña, MD</last_name>
      <phone>+34609353414</phone>
      <email>dpestanalag@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Angel Candela, MD</last_name>
      <email>acandela.hrc@salud.madrid.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario San Carlos (ICU)</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Paloma González-Arenas, MD</last_name>
      <phone>+34670576645</phone>
      <email>pgarenas@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundación Jiménez Díaz (ICU)</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Anxela Vidal, MD</last_name>
      <phone>+34680713669</phone>
      <email>anxelavidal@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>César Calvo, MD</last_name>
      <phone>+34618100522</phone>
      <email>Cperez@fjd.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Doce de Octubre (ICU)</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Isidro Prieto, MD</last_name>
      <phone>+34667762133</phone>
      <email>isidro.prieto@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>Mario Chico, MD</last_name>
      <phone>+34679328904</phone>
      <email>murgchico@yahoo.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz (Anesthesia)</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Emilio Maseda, MD</last_name>
      <phone>+34629018689</phone>
      <email>emilio.maseda@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz (ICU)</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>José M Añón, MD</last_name>
      <phone>+34620152794</phone>
      <email>jesus.villar54@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Juan C Figueira, MD</last_name>
      <phone>+34619182014</phone>
      <email>luarnaria@yahoo.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de Arrixaca (Anesthesia)</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Carlos García-Palenciano, MD</last_name>
      <phone>+34629721053</phone>
      <email>carlos.garciapalenciano@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Piedad Martinez-Gil, MD</last_name>
      <phone>+34615067008</phone>
      <email>pimagil@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de Arrixaca (ICU)</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Domingo Martínez, MD</last_name>
      <phone>+34670334050</phone>
      <email>dmbct1@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Juan A Soler, MD</last_name>
      <phone>+34661764387</phone>
      <email>juasobar@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Regional de Malaga Carlos Haya (ICU)</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Juan M Mora-Ordoñez, MD</last_name>
      <phone>+34666940647</phone>
      <email>jumouci@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clínica Universidad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Pablo Monedero, MD</last_name>
      <phone>+34685561229</phone>
      <email>pmonedero@unav.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Montecelo (Anesthesia)</name>
      <address>
        <city>Pontevedra</city>
        <zip>36071</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Marina Varela, MD</last_name>
      <phone>+34607358008</phone>
      <email>marina.varela.duran@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Pilar Diaz-Parada, MD</last_name>
      <phone>+34686101085</phone>
      <email>pilar.diaz.parada@sergas.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Nuestra Señora de Candelaria (ICU)</name>
      <address>
        <city>Santa Cruz De Tenerife</city>
        <zip>38010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Raquel Montiel, MD</last_name>
      <phone>+34617749631</phone>
      <email>raquelmontiel@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Dacil Parrilla, MD</last_name>
      <phone>+34600559881</phone>
      <email>gudru74@yahoo.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital General de Segovia (ICU)</name>
      <address>
        <city>Segovia</city>
        <zip>40002</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Alec Tallet, MD</last_name>
      <phone>+34679327648</phone>
      <email>alectaes@me.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia (Anesthesia)</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Gerardo Aguilar, MD</last_name>
      <phone>+34639715165</phone>
      <email>gaguilar.aguilar1@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>José A Carbonell, MD</last_name>
      <phone>+34605472557</phone>
      <email>joseacarbonell19@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia (ICU)</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>José Ferreres, MD</last_name>
      <phone>+34627557288</phone>
      <email>ferreresj@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>María L Blasco, MD</last_name>
      <phone>+34609231344</phone>
      <email>mablas13@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valladolid (Anesthesia)</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>José I Gómez-Herreras, MD</last_name>
      <phone>+34693417969</phone>
      <email>jgomez012001@yahoo.es</email>
    </contact>
    <contact_backup>
      <last_name>Mario Lorenzo-López, MD</last_name>
      <phone>+34654860101</phone>
      <email>mariolorenzo17@yahoo.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Río Hortega (Anesthesia)</name>
      <address>
        <city>Valladolid</city>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>César Aldecoa, MD</last_name>
      <phone>+34657500031</phone>
      <email>cesar.aldecoa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jesús Rico, MD</last_name>
      <phone>+34609024076</phone>
      <email>jricofe@saludcastillayleon.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Río Hortega (ICU)</name>
      <address>
        <city>Valladolid</city>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Lorena Fernández, MD</last_name>
      <phone>+34626479670</phone>
      <email>mlfernandezrod@saludcastillayleon.es</email>
    </contact>
    <contact_backup>
      <last_name>Pablo Blanco-Schweizer, MD</last_name>
      <phone>+34686892299</phone>
      <email>pblancosc@saludcastillayleon.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Concha (ICU)</name>
      <address>
        <city>Zamora</city>
        <zip>49022</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Concepción Tarancón, MD</last_name>
      <phone>+34609591652</phone>
      <email>fcontama@yahoo.es</email>
    </contact>
    <contact_backup>
      <last_name>Silvia Cortés-Díaz, MD</last_name>
      <phone>+34616290921</phone>
      <email>silviamcortesdiaz@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Severo Ochoa (ICU)</name>
      <address>
        <city>Leganés</city>
        <state>´Madrid</state>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Trinidad Puente, MD</last_name>
      <phone>+34699883428</phone>
      <email>tpuente_12@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Villar J, Ferrando C, Martínez D, Ambrós A, Muñoz T, Soler JA, Aguilar G, Alba F, González-Higueras E, Conesa LA, Martín-Rodríguez C, Díaz-Domínguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, Añón JM, Fernández RL, González-Martín JM; dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7.</citation>
    <PMID>32043986</PMID>
  </reference>
  <reference>
    <citation>RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. 2020 Jul 17. doi: 10.1056/NEJMoa2021436. [Epub ahead of print]</citation>
    <PMID>32678530</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 5, 2020</study_first_submitted>
  <study_first_submitted_qc>September 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2020</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr. Negrin University Hospital</investigator_affiliation>
    <investigator_full_name>Jesus Villar</investigator_full_name>
    <investigator_title>Senior scientist</investigator_title>
  </responsible_party>
  <keyword>Acute respiratory failure</keyword>
  <keyword>ARDS</keyword>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

